entertainment -WSS

entertainment

author：leisure time 2025-09-27 09:44:46 - browse：1348

Colorful one hundred dollar bills -- health tech coverage from STAT — Adobe

Hospitals aren’t usually in the business of selling technology tools. But that’s changing thanks to a collision of financial pressures and an explosion of new technology that could both improve patients’ health and ease the burden of administrative tasks on limited staff.

At the J.P. Morgan Healthcare conference, an exclusive, invitation-only event for investors, several influential health systems like Mayo Clinic and Mass General Brigham doubled down on new revenue streams including advising companies building artificial intelligence tools or licensing out custom built products as they brace for a tough 2024.

Selling tech isn’t entirely new: a subset of hospitals and academic centers have been licensing out risk models and health record tools for decades. But now, a “perfect storm” of shrinking profit margins and philanthropic dollars, workforce shortages and rising labor costs is driving more hospitals to explore selling new technology they have built, like scheduling or clinical note summary tools, more than they have before, according to Dana Rollison, chief data officer at Moffitt Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Hearing on Medicare drug price negotiation gets unusually heated

WSS

An inside look at PIPEs, biotech's buzzy new financing tool

Medical device lobby: We're tired of waiting on Medicare coverage

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

FDA panel to weigh approval of NurOwn, controversial ALS drug

It's been 20 years since Dolly the sheep. Where's my clone?

What Congress can do to address the rural doctor shortage

leisure time

entertainment

explore

Continuity nursing helped my family in our darkest PICU moments

International team creates first chimeric human

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

It's been 20 years since Dolly the sheep. Where's my clone?

Moonlake's readout produced a cash windfall. Risks remain

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

DIEP, the 'gold standard' of breast reconstruction, is under threat

Senate HELP committee spars over health care workforce policies

Wildfire smoke exposes gaps in outdoor worker protections

Pfizer highlights cancer drugs it thinks could reignite investor interest

hotspot

Flu vaccine offering decent levels of protection this winter, new data show

International team creates first chimeric human

Microbiome research is starting to find links to chronic diseases

Congress gives doctors Medicare pay bump

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

RaDonda Vaught to speak at CommonSpirit event on patient safety

entertainment

explore

entertainment

explore